Extracellular matrix proteins influence phenotype and cytokine expression in human breast cancer cell lines

European Cytokine Network

Volumn 13, Issue 2, 2002, Pages 234-240

  Hirtenlehner, Kora ^a   Pec, Martina ^a   Kubista, Ernst ^a   Singer, Christian F ^a  

^a NONE   (Austria)

Author keywords

Breast cancer; Cell line; Cytokine expression pattern; Extracellular matrix (ECM); Malignant potential; Tumor cell phenotype

Indexed keywords

COLLAGEN TYPE 1; COLLAGEN TYPE 4; CYTOKINE; FIBRONECTIN; HORMONE; LAMININ; POLY DEXTRO LYSINE; SCLEROPROTEIN; INTERLEUKIN 1; TGFB1 PROTEIN, HUMAN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; BREAST CARCINOMA; CANCER CELL; CANCER GROWTH; CANCER INVASION; CELL CULTURE; CELL KINETICS; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENVIRONMENTAL FACTOR; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; MALIGNANT TRANSFORMATION; PHENOTYPE; PROTEIN EXPRESSION; STROMA; BIOSYNTHESIS; BREAST TUMOR; FEMALE; PHYSIOLOGY;

BREAST NEOPLASMS; CYTOKINES; EXTRACELLULAR MATRIX PROTEINS; FEMALE; HUMAN; INTERLEUKIN-1; NEOPLASM INVASIVENESS; PHENOTYPE; SUPPORT, NON-U.S. GOV'T; TRANSFORMING GROWTH FACTOR BETA; TUMOR CELLS, CULTURED; HUMANS; TRANSFORMING GROWTH FACTOR BETA1;

EID: 0035991498     PISSN: 11485493     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Tissue architecture and breast cancer: The role of extracellular matrix and steroid hormones
2. The distribution of fibronectin, laminin and tetranectin in human breast cancer with special attention to the extracellular matrix
3. Cell-cell and cell-matrix interactions during breast cancer progression
4. The role of cell adhesion molecules in cancer invasion and metastasis
5. Extracellular matrix remodeling as a regulator of stromal-epithelial interactions during mammary gland development, involution and carcinogenesis
6. MCF-7 breast carcinoma cells overexpressing FGF-1 form vascularized, metastatic tumors in ovarectomized or tamoxifen-treated nude mice
7. Expression of fibroblast growth factor 1 is lower in breast cancer than in normal human breast
8. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in breast cancer
9. Progestin regulation of vascular endothelial growth factor in human breast cancer cells
10. Vascular endothelial growth factor and platelet-derived growth factor are potential angiogenic and metastatic factors in human breast cancer
11. Expression of the angiogenic vascular endothelial cell growth factor, acidic and basic fibroblast growth factor, tumor growth factor β-1, platelet-derived endothelial cell growth factor, placenta growth factor and pleiotrophin in human primary breast cancer and its relation to angiogenesis
12. Expression of growth factors, growth inhibiting factors and their receptors in invasive breast cancer. I: An inventory in search of autocrine and paracrine loops
13. Expression of cytokine messenger RNA in normal and neoplastic human breast tissue: Identification of interleukin-8 as a potential regulatory factor in breast tumours
14. Antitumor activity of endostatin against carcinogen-induced rat primary mammary tumors
15. A human cell line from a pleural effusion derived from a breast carcinoma
16. Breast tumor cell lines from pleural effusions
17. 1,25-Dihydroxyvitamin D3 specifically binds to a human breast cancer cell line (T47D) and stimulates growth
18. Whole-cell uptake and nuclear localisation of 1,25-dihydroxycholecalciferol by breast cancer cells (T47D) in culture
19. Partial replacement of serum by selenite, transferrin, albumin, and lecithin on haemopoietic cell culture
20. Media and growth requirements
21. Cellular changes involved in conversion of normal to malignant breast: Importance of the stromal reaction
22. Insulin-like growth factor mediated stromal-epithelial interactions in human breast cancer
23. Malignant breast epithelium selects for insulin-like growth factor II expression in breast stroma: Evidence for paracrine function
24. FGF signaling activates STAT1 and p21 and inhibits the estrogen response and proliferation of MCF-7 cells
25. Growth factors in breast cancer
26. Genomic cross-talk between the estrogen receptor and growth factor regulatory pathways in estrogen target tissues
27. Modulation of human breast cancer cell adhesion by estrogens and antiestrogens
28. Antagonistic effects of laminin and fibronectin in cell-to-cell and cell-to-matrix interactions in MCF-7 cultures
29. Interactions between tumoral MCF-7 cells and fibroblasts on matrigel and purified laminin
30. Laminin inhibits estrogen action in human breast cancer cells
31. Interleukin-1 family expression in human breast cancer: Interleukin-1 receptor antagonist
32. Evidence that transforming growth factor-beta is a hormonally regulated negative growth factor in human breast cancer cells
33. Transforming growth factor β: Biological function and chemical structure
34. Roles of the matrix metalloproteinases in mammary gland development and cancer
35. Matrix metalloproteinases and their inhibitors in connective tissue remodeling
36. Matrix metalloproteinases: A review
37. Clinical applications of research on angiogenesis
38. Angiogenesis
39. The FGF family of growth factors and oncogenes
40. Tumors: Wounds that do not heal. Similarities between tumor stroma generation and wound healing
41. Contributions of tumor and stromal matrix metalloproteinases to tumor progression, invasion and metastasis
42. The multiple roles of tumour stroma